Hangzhou AGS Medtech(688581.SH) granted 391,500 restricted shares at a price of 70 yuan per share.

18:42 07/09/2023

Hangzhou AGS Medtech(688581.SH) announcement, the restrictive stock grant conditions stipulated in the company's 2023 restricted stock incentive plan have been achieved. The company has determined September 7, 2023 as the initial grant date for the restricted stocks of this equity incentive plan. It will grant 391,500 restricted stocks at a price of 70 yuan per share to 69 eligible incentive recipients.

PROSP INV HOLD (00310) has subscribed 612,000 Hong Kong dollars for the shares of the listed company. Trading will resume on March 13th.

VISEN PHARMA-B(02561) released its annual performance, with research and development costs reaching 93.48 million yuan, an increase of 3.27% year-on-year.

US Stock Market Move | Himax Technologies, Inc. Sponsored ADR (HIMX.US) soared over 23% in early trading, accumulating a 52% increase over the past 4 trading days.

PROSP INV HOLD (00310) has subscribed 612,000 Hong Kong dollars for the shares of the listed company. Trading will resume on March 13th.

VISEN PHARMA-B(02561) released its annual performance, with research and development costs reaching 93.48 million yuan, an increase of 3.27% year-on-year.

US Stock Market Move | Himax Technologies, Inc. Sponsored ADR (HIMX.US) soared over 23% in early trading, accumulating a 52% increase over the past 4 trading days.